echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Peking University Public Health Risk Prediction Model: Using the Chinese Kadoorie Biobank to Build and Predict the Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease within 10 Years

    Neurology: Peking University Public Health Risk Prediction Model: Using the Chinese Kadoorie Biobank to Build and Predict the Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease within 10 Years

    • Last Update: 2022-05-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cardiovascular disease (CVD), including ischemic heart disease (IHD), ischemic stroke (IS), and hemorrhagic stroke (HS), is the leading cause of the global disease burden


    Cardiovascular disease (CVD), including ischemic heart disease (IHD), ischemic stroke (IS), and hemorrhagic stroke (HS), is the leading cause of the global disease burden


    The first is to differentiate the risks between IS and HS


    Based on the China Kadoorie Biobank (CKB), one of the largest population-based cohorts in the world, researchers have recently established practical disease-specific and overall cardiac outcomes based on widely available variables in Chinese RHR, including IHD, IS, and HS.


    The researchers established gender models of ischemic heart disease (IHD), ischemic stroke (IS) and hemorrhagic stroke (HS), and total cardiovascular disease (CVD) in the Chinese Kadoorie Biobank


    The researchers established gender models of ischemic heart disease (IHD), ischemic stroke (IS) and hemorrhagic stroke (HS), and total cardiovascular disease (CVD) in the Chinese Kadoorie Biobank


    • During the 11-year follow-up period, 489,596 people participated in the model study, including 45,947 IHD, 43,647 IS, and 11,168 HS patients


      In addition to excluding blood lipids, this cardiovascular risk prediction model was also able to differentiate between IHD and stroke subtypes well


      Classification of evidence: This study provides class I evidence that a predictive model incorporating accessible clinical variables predicts the 10-year risk of ischemic heart disease, ischemic stroke, and hemorrhagic stroke in a Chinese population aged 30-79 years


      Source: Yang S, Han Y, Yu C, et al.
      Development of Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank [published online ahead of print, 2022 Apr 11].
      Neurology.
      2022;10.
      1212/WNL.
      0000000000200139.
      doi:10.
      1212/WNL.
      0000000000200139 Yang S, Han Y, Yu C, et al.
      Development of Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank [published online ahead of print, 2022 Apr 11].
      Neurology.
      2022;10.
      1212/WNL.
      0000000000200139.
      doi:10.
      1212/WNL.
      0000000000200139Leave

      a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.